![Humens logo](/sites/default/files/styles/etudes_thumbs/public/2024-02/logo_Humens.jpg?itok=Sr1RxrBZ)
Stories
Mid-large buyout
Gene therapy biotech company.
Healthcare - Kurma Partners
StatusIn portfolio
Investment date04/2017
SectorHealthcare
LocationEurope
Provider of LPWA networks and application softwares for the IoT
Venture - Smart city
StatusIn portfolio
Investment date04/2017
SectorTech-enabled
LocationEurope
French confectionary group
Mid-large buyout
StatusIn portfolio
Investment date05/2017
SectorConsumer
LocationEurope
Importer and manufacturer of kitchen, decoration, toys and high tech products
Corporate Financing
StatusIn portfolio
Investment date05/2017
SectorConsumer
LocationEurope
Manufacturer of single-use sterelized surgical devices
Small-mid buyout
StatusIn portfolio
Investment date05/2017
SectorHealthcare
LocationEurope
French leading player in digital transformation focusing on open source solutions
Small-mid buyout
StatusIn portfolio
Investment date05/2017
SectorTech-enabled
LocationEurope
Eurazeo Investment Manager (EIM) and Eurazeo Mid Cap (EMC) are merging to form Eurazeo Global Investor (EGI)